Machine Learning Analysis in the Field of Heart Disease

Abstract

Machine learning (ML) has emerged as a transformative force in cardiovascular disease research, offering innovative approaches to prevention, diagnosis, and treatment. This report provides an overview of the current landscape of ML applications in cardiology, highlighting its potential to revolutionize the field. Key ML algorithms such as Support Vector Machine (SVM), Random Forests, Adaboost, XGBoost, and Convolutional Neural Networks (CNN) are discussed for their unique capabilities in handling complex cardiovascular data and improving disease prediction and risk stratification. Notably, the integration of feature selection techniques with ML algorithms enables the identification of biomarkers and clinical indicators, facilitating personalized care and targeted interventions. The potential of ML extends to early disease diagnosis, patient stratification, and the design of new therapeutic strategies, thereby transforming cardiology into a domain of precision medicine. While the advancements are promising, there is a pressing need for further research to enhance the interpretability, generalizability, and integration of ML models into real-world healthcare settings. Collaborative efforts between ML experts, healthcare providers, and policymakers are essential to address regulatory, ethical, and privacy concerns and to fully harness the capabilities of ML in cardiovascular medicine.